Silodosin Capsule
Product Images NDC 68180-741

10 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Silodosin (NDC 68180-741). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Silodosin (9a808ee1 339e 42a3 B55c B655c9d1fcb8 01)

Silodosin (9a808ee1 339e 42a3 B55c B655c9d1fcb8 01)
Chemical structure of silodosin, showing its molecular composition and bonds in a two-dimensional diagram.*
FDA Label Image

Figure 1 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 02)

Figure 1 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 02)
A line graph showing Silodosin concentration (ng/mL) over time (hours). The graph depicts concentration peaking between 3 and 4 hours, then gradually declining until about 24 hours. Vertical error bars indicate variability at each time point.*
FDA Label Image

Figure 2 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 03)

Figure 2 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 03)
A line graph showing change from baseline in IPSS total score over 84 days for Silodosin 8 mg compared to placebo. The X-axis represents days (B, 3.5, 7, 14, 28, 84/LOCF) and the Y-axis represents change from baseline. Silodosin shows a greater decrease in IPSS score over time relative to placebo, with statistically significant differences (p<0.0001) indicated near day 84.*
FDA Label Image

Figure 3 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 04)

Figure 3 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 04)
A line graph showing the change from baseline in IPSS Total Score over time in days for Silodosin 8 mg versus placebo. The graph illustrates a greater reduction in IPSS Total Score for Silodosin 8 mg, with statistical significance indicated (p<0.0001). The x-axis denotes time points from baseline (B) to day 84/LOCF, and the y-axis measures the change in score.*
FDA Label Image

Figure 4 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 05)

Figure 4 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 05)
Line chart showing change from baseline in Qmax (mL/sec) over days for Silodosin 8 mg compared to placebo. Silodosin group shows a rapid increase by day 1, maintaining higher values than placebo through day 84/LOCF, with statistical significance (p<0.05) indicated at multiple points.*
FDA Label Image

Figure 5 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 06)

Figure 5 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 06)
Line graph comparing change from baseline in Qmax (mL/sec) over days for Silodosin 8 mg versus placebo. The x-axis represents days (Baseline, 1, 7, 14, 28, 84/LOCF), and the y-axis shows change from baseline in Qmax. Silodosin 8 mg shows a higher increase relative to placebo, with statistically significant differences (p<0.05) noted at day 84/LOCF.*
FDA Label Image

Image (Ede0cb6e B555 4b55 8875 75e51b5ccd54 137 1)

FDA Label Image

Image 2 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 07)

Image 2 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 07)
Silodosin Capsules 4 mg oral capsules packaging label with 30 capsules per container. The label includes the NDC 68180-740-06 and indicates the manufacturer as Lupin Pharmaceuticals, Inc., Naples, FL, USA, and Lupin Limited, India. Storage instructions and usual dosage directions are also present on the label.*
FDA Label Image

Image 3 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 08)

Image 3 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 08)
Silodosin Capsules 8 mg oral capsules label, showing 30 capsules per package. Manufactured for Lupin Pharmaceuticals, Inc., Naples, Florida, and manufactured by Lupin Limited, India. Features dosage and storage instructions, barcode, and the NDC 68180-741-06.*
FDA Label Image

Image 3 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 09)

Image 3 (9a808ee1 339e 42a3 B55c B655c9d1fcb8 09)
Silodosin Capsules 8 mg label by Lupin Pharmaceuticals, Inc. This label indicates capsules in a count of 90, for oral use. The label is primarily white with green and red highlights, displaying the NDC 68180-741-09, product name, strength, and storage instructions. It includes manufacturer information and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.